Tao Capital Management LP
CIK 1802967 · View on SEC EDGAR ↗
- Portfolio value
- $1.9B
- Positions
- 6
- As of
- June 30, 2026
Portfolio value QoQ: +1532.6% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 3
- Effective number of positions
- 1.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 5.62% Est. buys $1,821,475,684 · sells $57,851,965
Median holding: 6.0 quarters Tracked Q4 2024–Q2 2026 · 50.0% still held
- New positions
- 1
- Increased
- 1
- Decreased
- 1
- Closed
- 3
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +72.3% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.9% · Options excluded: 0.0%
Sector breakdown
Full portfolio 6 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: 84615Q103) | $1,818,691,932 | 93.75% | 10,644,340 | Up ×1 | |||
| TWST Twist Bioscience Corporation - Common Stock | $49,260,487 | 2.54% | 478,815 | $9,875,198 | Down ×1 | ||
| TSLA Tesla, Inc. - Common Stock | $36,276,750 | 1.87% | 86,250 | $4,213,312 | |||
| H Hyatt Hotels Corporation Class A Common Stock | $13,568,800 | 0.70% | 70,000 | $3,503,500 | |||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $11,275,950 | 0.58% | 21,000 | $283,080 | |||
| TXG 10x Genomics, Inc. - Common Stock | $10,868,201 | 0.56% | 283,469 | $6,391,601 | Up ×1 | ||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: 84615Q103) | $1,818,691,932 | 10,644,340 | 93.75% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| OUST | June 30, 2026 | 845,316 | $15,528,455 | -37.4% |
| MASS | June 30, 2026 | 568,981 | $3,482,164 | 19.2% |
| WRBY | June 30, 2026 | 134,473 | $2,833,346 | -9.9% |
| SONDQ | Dec. 31, 2025 | 80,188 | $101,839 | No longer tracked |
| BHILQ | March 31, 2025 | 50,704 | $99,887 | No longer tracked |
| DNA | Dec. 31, 2025 | 5,683 | $82,858 | -16.7% |